01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $1.33B
2 older moves run past ±150% (largest +360.5%); point at, tap or drag across the bars to read one.
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $1.33B | +360.5% | 10-K | |
| FY2024 | $289.9M | −54.9% | 10-K | |
| FY2023 | $642.8M | −34.0% | 10-K | |
| FY2022 | $973.6M | −30.8% | 10-K | |
| FY2021 | $1.41B | +117.3% | 10-K | |
| FY2020 | $647.3M | −30.3% | 10-K | |
| FY2019 | $928.5M | +35.0% | 10-K | |
| FY2018 | $688.0M | −17.4% | 10-K | |
| FY2017 | $832.6M | +57.6% | 10-K | |
| FY2016 | $528.3M | +18.2% | 10-K | |
| FY2015 | $447.0M | −52.4% | 10-K | |
| FY2014 | $939.4M | +158.3% | 10-K | |
| FY2013 | $363.7M | +43.7% | 10-K | |
| FY2012 | $253.1M | +9.3% | 10-K | |
| FY2011 | $231.6M | +22.2% | 10-K | |
| FY2010 | $189.6M | +87.2% | 10-K | |
| FY2009 | $101.3M | −1.3% | 10-K | |
| FY2008 | $102.6M | — | 10-K |
03—Questions
What is Edwards Lifesciences's current free cash flow?
Edwards Lifesciences (EW) annual free cash flow for 2025 was $1.33B, a 360.50% increase from 2024. Edwards Lifesciences free cash flow for the quarter ending June 30, 2026 was $585.0M.
What was Edwards Lifesciences's free cash flow in 2024?
Edwards Lifesciences annual free cash flow for 2024 was $289.9M, a 54.90% decline from 2023.
What was Edwards Lifesciences's free cash flow in 2023?
Edwards Lifesciences annual free cash flow for 2023 was $642.8M, a 33.98% decline from 2022.
What is Edwards Lifesciences's 5-year free cash flow CAGR?
Edwards Lifesciences free cash flow grew at a compound annual growth rate (CAGR) of 15.58% from FY2020 to FY2025, going from $647.3M to $1.33B over 5 years.
- Company
- Edwards Lifesciences
- Ticker
- EW
- Sector
- Other
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies